Twist Bioscience (TWST) EBIT (2018 - 2025)
Historic EBIT for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to -$32.9 million.
- Twist Bioscience's EBIT rose 503.41% to -$32.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$134.5 million, marking a year-over-year increase of 3548.43%. This contributed to the annual value of -$136.3 million for FY2025, which is 3829.72% up from last year.
- As of Q4 2025, Twist Bioscience's EBIT stood at -$32.9 million, which was up 503.41% from -$29.9 million recorded in Q3 2025.
- Over the past 5 years, Twist Bioscience's EBIT peaked at -$29.9 million during Q3 2025, and registered a low of -$88.9 million during Q2 2024.
- For the 5-year period, Twist Bioscience's EBIT averaged around -$48.1 million, with its median value being -$45.8 million (2022).
- In the last 5 years, Twist Bioscience's EBIT tumbled by 7058.52% in 2021 and then soared by 6612.76% in 2025.
- Over the past 5 years, Twist Bioscience's EBIT (Quarter) stood at -$55.9 million in 2021, then rose by 20.22% to -$44.6 million in 2022, then dropped by 5.26% to -$47.0 million in 2023, then rose by 26.25% to -$34.6 million in 2024, then increased by 5.03% to -$32.9 million in 2025.
- Its last three reported values are -$32.9 million in Q4 2025, -$29.9 million for Q3 2025, and -$30.1 million during Q2 2025.